# A Study for Patients With Acute Leukemia

> **NCT01214655** · PHASE1 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 33 (actual)

## Conditions studied

- Acute Leukemia

## Interventions

- **DRUG:** LY2523355

## Key facts

- **NCT ID:** NCT01214655
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Primary objective has been met in the absence of clinically meaningful remissions
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01214655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01214655, "A Study for Patients With Acute Leukemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01214655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*